USMJ Confirms $20 Million Marijuana and CBD Sales Growth Plans

Rhea-AI Summary

North American Cannabis Holdings (USMJ) has announced a strategic plan potentially adding $20 million in sales, leveraging opportunities in the adult-use marijuana market and the recently acquired EVERx CBD Sports Nutrition Beverage. With eligibility confirmed for the new adult-use marijuana cultivation license in New York, the company aims to capitalize on both markets, anticipating significant growth alongside its expanding ecommerce business. Highlights of this plan will be disclosed in a shareholder update scheduled for March 29.

Positive

• Potential to add $20 million in sales from adult-use marijuana and EVERx product.
• Eligibility confirmed for adult-use marijuana cultivation license in New York.
• Expansion of ecommerce business aligns with growth strategy.

Negative

• None.

Dallas, Texas, March 24, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today confirmed the company has developed a plan to that could add $20 million in sales on top of the company’s growing sales from its expanding ecommerce business.  The company also confirmed management plans to reveal highlights of the plan next week in a shareholder update scheduled for Tuesday, March 29^th.

The plan is to take advantage or the unexcepted opportunity to grow and sell adult use marijuana in addition to also rapidly capturing the opportunity for USMJ’s recently acquired CBD sports nutrition beverage.

USMJ has recently confirmed its eligibility to apply for the new adult-use marijuana cultivation license recently passed into law in the State of New York.

In February, New York passed a new law to provide provisional marijuana cultivation licenses to existing hemp businesses. 

USMJ has a subsidiary that has been growing hemp for CBD for the past four years.  The subsidiary has received an invitation from the New York Office of Cannabis Management (OCM) to apply for the provisional adult-use cannabis license.

USMJ also recently relaunched the EVERx CBD Sports Nutrition Beverage after acquiring the product line from Puration, Inc. (OTC Pink: PURA) in exchange for a royalty agreement as part of an overall reorganization executed by the co-controlling parent company of USMJ, PURA and Priority Aviation, Inc. (OTC Pink: PJET).

The EVERx CBD Sports Nutrition Beverage relaunch took place at Arnold Schwarzenegger’s annual Arnold Sports Festival.

Between the EVERx and adult use marijuana opportunities, USMJ has developed a plan that it believes can generate a potential $20 million in sales over the next two years separate from the sales that can be generated from the company’s expanding ecommerce business.

USMJ is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. The Company operates USMJ.com and is dedicated to Ongoing Cannabis Consumer Product Development that it can incubate into Future Spin-offs.

USMJ has one spin-off and dividend issuance so far in its cannabis incubation operational history having issued shares of Puration, Inc. (OTC Pink: PURA) in the past.  USMJ continues to work closely with PURA and recently acquired a CBD sports nutrition beverage product from PURA in a royalty agreement. The EVERx CBD Sports Nutrition Beverage acquired by USMJ is bottled by Alkame Holdings, Inc. (USOTC: ALKM).

Visit the company’s ecommerce site now and bookmark the site to watch for more coming announcements and updates: www.USMJ.com

Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

FAQ

What is North American Cannabis Holdings' stock symbol?

The stock symbol for North American Cannabis Holdings is USMJ.

When will USMJ announce its sales plan details?

USMJ plans to reveal details of its sales plan in a shareholder update on March 29.

What opportunities is USMJ pursuing?

USMJ is pursuing the adult-use marijuana market and the sales of the EVERx CBD Sports Nutrition Beverage.

What are the expected sales from the new plan by USMJ?

USMJ expects to add $20 million in sales over the next two years from its new plan.

Has USMJ received any licenses recently?

Yes, USMJ has confirmed its eligibility to apply for a new adult-use marijuana cultivation license in New York.